Rossano Rufini — investor profile photo

Rossano Rufini

Managing Partner and Board Member at Equita Capital SGR | Head of Private Equity

📍 Segrate, Lombardy, Italy🔄 Updated November 2026💼 10 investments📅 13 years investing🗓 Last invested Apr 2025
VC🌍 Italy
10
Total investments
0
Early stage
0
Mid stage
0
Late stage
13y
Years active

Portfolio

0 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
No investments found
Experience · 14 entries
All (14)
Investments (10)
Board (10)
2025
DEMEGLIO GIOIELLI
Board Member
Apr 2025
2022
Board Member
Sep 2022
Rattiinox has developed the third generation of radial diaphragm valves. These valves are extremely CIP-friendly due to the clean aseptic design of the valve bodies and radial diaphragm without any low - or zero - flow areas typical of weir-type valves. The diaphragms are machined from solid pre-compressed PTFE with low friction so even sticky biotech proteins slide off and extreme resistance to aggressive CIP chemicals and high SIP temperatures. The range includes 1/2", 3/4", 1", 1-1/2", 2", 2-1/2", 3" and 4" tank bottom, sample, in-line, POU, diverter,etc. - most with options of flow-behind the seat - and a vast range of combinations such as lower point CIP+SIP with steam trap, double block & bleed, aseptic transfer assemblies, etc. All valves are offered with a wide range of port options to guarantee optimum SIP-condensate drainage and permit extremely compact circuits with less tubes, elbows, no tees, no dead-legs (L/d=0), less hold-up volume and less welds to validate.
Board Member
Jul 2022
Founded in 1987, Clonit srl was one of the first Italian companies operating in the field of biotechnology. Since the beginning, the company has worked to develop innovative and reliable analytical methods in the field of In Vitro diagnostics using molecular biology techinques. The systems are useful for human diagnostic with particular attention to the detection of viral, bacteria and protozoa infections, genetic mutations and oncological diseases. The scientific innovations were transferred into ready to use diagnostic kits that, for the operating user-friendliness and the quality, are optimal for routine diagnostic laboratories. Proprietary technology is covered by a number of International patents some of which have been higly innovative for the field, such as the invention related to a solid state PCR amplification mix using thermoregulated polymers. The standardization of internal quality control system and cross-checks in outer reference labs have made Clonit able to assure the highest standards of care and quality (ISO 9001:2008 and ISO13485:2004 Certified). The company is registered and authorized from the Italian Ministry of the Health for the production of Medical Diagnostic devices Clonit offers to its customers an unrivalled experience in molecular biology.
2020
Equita Capital SGR
Managing Partner
Jan 2020
Equita Investimenti S.p.A.
Board Member
Jan 2020
Show all 14 entries ↓
Investment activity
2013–2025 · 10 investments
201312017220182202022022220251
Recent (last 2 years)Earlier
Investor lists
Lists that match Rossano's portfolio